Drug Trial Radar · NCT05310422
Safety Study of Tivanisiran to Treat Dry Eye
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
301
Actual
Start
Mar 24, 2022
Primary completion
Oct 11, 2023
Study completion Oct 11, 2023
Sponsor
- Lead sponsor
- Sylentis, S.A.Industry
- Sponsor type
- Industry
- First posted
- Apr 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will examine the safety of tivanisiran sodium eye drops versus vehicle when dosed once daily for 1 year in subjects with signs and symptoms of dry eye disease (DED).
Conditions
- Dry Eye Disease
Interventions
Tivanisiran sodium ophthalmic solutionDrug
1 drop in the affected eye(s) once daily
Vehicle ophthalmic solutionDrug
1 drop in the affected eye(s) once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number and Percentage of Subjects With Ocular and Non-ocular Treatment Emergent Adverse Events (TEAEs) for 1 YearTime frame: 1 year
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Sylentis Investigative Site
Chandler, Arizona
Sylentis Investigative Site
Phoenix, Arizona
FYDES Investigative Site
Glendale, California
Sylentis Investigative Site
Hemet, California
Sylentis Investigative Site
Los Angeles, California
Sylentis Investigative Site
Murrieta, California
Sylentis Investigative Site
Newport Beach, California
FYDES Investigative Site
Delray Beach, Florida
FYDES Investigative Site
Jacksonville, Florida
Sylentis Investigative Site
Largo, Florida
Sylentis Investigative Site
Morrow, Georgia
Sylentis Investigative Site
Fraser, Michigan
Sylentis Investigative Site
Kansas City, Missouri
FYDES Investigative Site
St Louis, Missouri
Sylentis Investigative Site
Washington, Missouri
Sylentis Investigative Site
Rochester, New York
Sylentis Investigative Site
Asheville, North Carolina
Sylentis Investigative Site
Garner, North Carolina
Sylentis Investigative Site
Cranberry Township, Pennsylvania
Sylentis Investigative Site
Rapid City, South Dakota
Sylentis Investigative Site
Memphis, Tennessee
Sylentis Investigative Site
Austin, Texas
FYDES Investigative Site
El Paso, Texas
Sylentis Investigative Site
San Antonio, Texas
Sylentis Investigative Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.